Xortx Therapeutics Inc (XRTX)

$2.31 +0.16 (7.44%)
Market Cap 4.20M
Revenue (ttm) 0.00
Net Income (ttm) -2.66M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 14,200
Avg Vol 12,256
Day's Range N/A - N/A
Shares Out 1.82M
Stochastic %K 57%
Beta 0.75
Analysts Strong Buy
Price Target $70.00

Company Profile

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada. It develops XRx-026, which is in Phase III for the treatment of gout; XRx-008, which is in Phase II for the treatment of autosomal dominant polycystic kidney disease; XRx-101, which is in Phase II for the treatment of acute kidney injury associated with respiratory virus infection, including sepsis and coronavirus;...

Industry: Biotechnology
Sector: Healthcare
Phone: 403 455 7727
Address:
3710 - 33rd Street NW, Calgary, Canada
taxidriver514
taxidriver514 Sep. 4 at 4:25 PM
$BIAF $CYCU $XRTX
0 · Reply
focafoca99
focafoca99 Sep. 4 at 1:09 PM
$XRTX terminated its prior IR agency agreement and re-engaged IR Agency after completing its TSX Venture delisting.
0 · Reply
LookaLike
LookaLike Sep. 2 at 8:46 PM
$XRTX going up
1 · Reply
focafoca99
focafoca99 Aug. 28 at 11:19 AM
$XRTX terminated its investor-relations agreement and postponed the program while it pursues a TSX-V delisting.
0 · Reply
LookaLike
LookaLike Aug. 28 at 6:59 AM
$XRTX this was a tenbagger in the past, I remember a few years ago it went to the moon. Problem was that it never held the gains and it always came back
0 · Reply
honestrick
honestrick Aug. 27 at 9:18 PM
$XRTX 2,198 watchers just a start ....GLTA....
0 · Reply
LookaLike
LookaLike Aug. 27 at 3:16 PM
$XRTX going Up again
0 · Reply
LookaLike
LookaLike Aug. 27 at 12:27 PM
$XRTX why the premarket Volume, I see no news
0 · Reply
honestrick
honestrick Aug. 27 at 11:55 AM
$XRTX Would be nice ...
0 · Reply
LookaLike
LookaLike Aug. 25 at 6:29 PM
$XRTX IT IS moving
0 · Reply
Latest News on XRTX
XORTX Slips 10% As Investor Relations Program Is Terminated And Postponed

2026-08-28T13:37:38.000Z - 10 days ago

XORTX Slips 10% As Investor Relations Program Is Terminated And Postponed

Xortx Therapeutics terminates investor relations, marketing agreement

2026-08-28T11:10:20.000Z - 10 days ago

Xortx Therapeutics terminates investor relations, marketing agreement

XORTX Announces Termination and Postponement of Investor Relations Program

2026-08-28T11:02:01.000Z - 10 days ago

XORTX Announces Termination and Postponement of Investor Relations Program

XORTX Announces Termination and Postponement of Investor Relations Program

Fri, 28 Aug 2026 07:00:00 -0400 - 10 days ago

XORTX Announces Termination and Postponement of Investor Relations Program

XORTX Therapeutics Registration statement: Q2 2026

Aug 14, 2026, 10:35 PM EDT - 24 days ago

XORTX Therapeutics Registration statement: Q2 2026

XORTX Therapeutics Registration statement: Q2 2026

Aug 14, 2026, 10:35 PM EDT - 24 days ago

XORTX Therapeutics Registration statement: Q2 2026

XORTX Announces Director Resignation

Fri, 31 Jul 2026 17:00:00 -0400 - 5 weeks ago

XORTX Announces Director Resignation

XORTX Appoints New Director

Wed, 29 Jul 2026 07:00:00 -0400 - 5 weeks ago

XORTX Appoints New Director

XORTX Therapeutics Transcript: Transcript

Jul 8, 2026, 4:06 PM EDT - 2 months ago

XORTX Therapeutics Transcript: Transcript

XRTX Welcomes Mika Grasso as New Co-CEO for Finance and Public Markets

2026-06-15T12:54:34.000Z - 2 months ago

XRTX Welcomes Mika Grasso as New Co-CEO for Finance and Public Markets

Xortx Therapeutics announces Mika Grasso as co-CEO

2026-06-15T11:27:57.000Z - 2 months ago

Xortx Therapeutics announces Mika Grasso as co-CEO

XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO

Mon, 15 Jun 2026 07:00:00 -0400 - 2 months ago

XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO

XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange

Fri, 12 Jun 2026 17:00:00 -0400 - 2 months ago

XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange

XORTX Announces Closing of US$5 Million Public Offering

Tue, 19 May 2026 07:00:00 -0400 - 3 months ago

XORTX Announces Closing of US$5 Million Public Offering

E.F. Hutton & Co. Serves as Exclusive Placement Agent on XORTX Therapeutics Inc. $5 Million Public Offering

Mon, 18 May 2026 11:20:00 -0400 - 3 months ago

E.F. Hutton & Co. Serves as Exclusive Placement Agent on XORTX Therapeutics Inc. $5 Million Public Offering

XRTX Announces Public Offering of Shares

2026-05-14T20:33:59.000Z - 3 months ago

XRTX Announces Public Offering of Shares

Xortx Therapeutics 2.66M share Spot Secondary priced at $1.88

2026-05-14T19:08:33.000Z - 3 months ago

Xortx Therapeutics 2.66M share Spot Secondary priced at $1.88

XRTX

XORTX Announces US$5 Million Public Offering

Thu, 14 May 2026 07:00:00 -0400 - 3 months ago

XORTX Announces US$5 Million Public Offering

XORTX Regains Nasdaq Compliance, Stock Up

2026-04-21T14:45:55.000Z - 4 months ago

XORTX Regains Nasdaq Compliance, Stock Up

XRTX Achieves Nasdaq Compliance Following Share Price Recovery

2026-04-21T14:32:51.000Z - 4 months ago

XRTX Achieves Nasdaq Compliance Following Share Price Recovery

Xortx Therapeutics meets Nasdaq continued listing requirements

2026-04-21T12:45:47.000Z - 4 months ago

Xortx Therapeutics meets Nasdaq continued listing requirements

XORTX Closes Acquisition Of Kidney Anti-fibrotic Asset From Vectus; Stock Down

2026-04-14T06:56:22.000Z - 4 months ago

XORTX Closes Acquisition Of Kidney Anti-fibrotic Asset From Vectus; Stock Down

Xortx Therapeutics to effect 5-for-1 share consolidation on April 6

2026-04-01T17:05:46.000Z - 5 months ago

Xortx Therapeutics to effect 5-for-1 share consolidation on April 6

XORTX Confirms Effective Date of Share Consolidation

Wed, 01 Apr 2026 13:00:00 -0400 - 5 months ago

XORTX Confirms Effective Date of Share Consolidation

XORTX Announces Results of Annual and Special Meeting of Shareholders

Thu, 26 Mar 2026 18:00:00 -0400 - 5 months ago

XORTX Announces Results of Annual and Special Meeting of Shareholders

XORTX Announces Change of Effective Date of Share Consolidation

Thu, 26 Mar 2026 16:32:00 -0400 - 5 months ago

XORTX Announces Change of Effective Date of Share Consolidation

XORTX Announces Share Consolidation

Wed, 25 Mar 2026 18:15:00 -0400 - 5 months ago

XORTX Announces Share Consolidation

Xortx Therapeutics announces three new director nominees

2026-03-18T11:26:41.000Z - 5 months ago

Xortx Therapeutics announces three new director nominees

Xortx reports proxy firms recommend shareholders vote ‘FOR’ share consolidation

2026-03-13T11:11:51.000Z - 5 months ago

Xortx reports proxy firms recommend shareholders vote ‘FOR’ share consolidation

XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation

Fri, 13 Mar 2026 07:00:00 -0400 - 5 months ago

XORTX Reports that Independent Proxy Advisory Firms Recommend XORTX Shareholders Vote “For” the Share Consolidation

XORTX Therapeutics (XRTX) Announces Key Shareholder Meeting Agenda

2026-03-05T12:33:09.000Z - 6 months ago

XORTX Therapeutics (XRTX) Announces Key Shareholder Meeting Agenda

Xortx Therapeutics announces filing of meeting documents

2026-03-05T12:18:22.000Z - 6 months ago

Xortx Therapeutics announces filing of meeting documents

Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

2026-02-05T09:34:03.000Z - 7 months ago

Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

XORTX Extends Closing Of Renal Anti-Fibrotic Therapeutic Program Acquisition; Stock Soars

2026-02-05T07:10:06.000Z - 7 months ago

XORTX Extends Closing Of Renal Anti-Fibrotic Therapeutic Program Acquisition; Stock Soars

Xortx Therapeutics prices 1.75M shares at 63c in registered direct offering

2025-10-21T12:20:49.000Z - 10 months ago

Xortx Therapeutics prices 1.75M shares at 63c in registered direct offering

XORTX Announces Pricing of US$1.1 Million Registered Direct Offering

Tue, 21 Oct 2025 08:00:00 -0400 - 10 months ago

XORTX Announces Pricing of US$1.1 Million Registered Direct Offering

XORTX Therapeutics (XRTX) Secures Nasdaq Extension to Meet Bid Price Rule

2025-10-21T06:55:29.000Z - 10 months ago

XORTX Therapeutics (XRTX) Secures Nasdaq Extension to Meet Bid Price Rule

XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

Mon, 20 Oct 2025 20:34:00 -0400 - 10 months ago

XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Mon, 20 Oct 2025 18:45:00 -0400 - 10 months ago

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Why Is XORTX Therapeutics Stock (XRTX) Up 20% Today?

2025-10-17T13:42:59.000Z - 10 months ago

Why Is XORTX Therapeutics Stock (XRTX) Up 20% Today?

XORTX (XRTX) Acquires Renal Therapeutic Program from Vectus

2025-10-17T12:35:39.000Z - 10 months ago

XORTX (XRTX) Acquires Renal Therapeutic Program from Vectus

Xortx to acquire Renal Anti-Fibrotic Therapeutic Program from Vectus for $3M

2025-10-17T11:05:16.000Z - 10 months ago

Xortx to acquire Renal Anti-Fibrotic Therapeutic Program from Vectus for $3M

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

Fri, 17 Oct 2025 07:00:00 -0400 - 10 months ago

XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

Xortx Therapeutics files to sell 4.76M common shares

2025-09-25T20:25:29.000Z - 11 months ago

Xortx Therapeutics files to sell 4.76M common shares

XORTX Therapeutics goes ‘toe to toe’ with gout by accelerating its lead drug program targeting this complex disease

2025-09-09T13:01:00.000Z - 12 months ago

XORTX Therapeutics goes ‘toe to toe’ with gout by accelerating its lead drug program targeting this complex disease

Xortx Therapeutics initiates IND preparation for XORLO in gout program

2025-09-03T11:11:43.000Z - 1 year ago

Xortx Therapeutics initiates IND preparation for XORLO in gout program

XORTX Initiates IND Preparation for XORLO™ in Gout Program

Wed, 03 Sep 2025 07:00:00 -0400 - 1 year ago

XORTX Initiates IND Preparation for XORLO™ in Gout Program

XORTX Completes USD $114,500 Private Placement

Fri, 08 Aug 2025 19:54:00 -0400 - 1 year ago

XORTX Completes USD $114,500 Private Placement

Xortx Therapeutics announces planned goals for 2026

2025-08-07T12:02:26.000Z - 1 year ago

Xortx Therapeutics announces planned goals for 2026

Xortx Therapeutics prices 156,849 units at 73c in private placement

2025-07-31T11:20:31.000Z - 1 year ago

Xortx Therapeutics prices 156,849 units at 73c in private placement

XORTX Completes Non-Brokered Private Placement of Units

Tue, 22 Jul 2025 19:59:00 -0400 - 1 year ago

XORTX Completes Non-Brokered Private Placement of Units

XORTX Announces USD $925,000 Private Placement

Thu, 26 Jun 2025 07:00:00 -0400 - 1 year ago

XORTX Announces USD $925,000 Private Placement

Xortx Therapeutics prices 3.41M units at 88c in private placement

2025-05-19T11:15:25.000Z - 1 year ago

Xortx Therapeutics prices 3.41M units at 88c in private placement

XORTX Announces USD $3 Million Offering

May 19, 2025, 7:00 AM EDT - 1 year ago

XORTX Announces USD $3 Million Offering

Xortx Therapeutics provides update on FDA Type B meeting request

2025-04-30T11:14:55.000Z - 1 year ago

Xortx Therapeutics provides update on FDA Type B meeting request

Xortx Therapeutics announces grant of European patent

2025-04-28T11:11:02.000Z - 1 year ago

Xortx Therapeutics announces grant of European patent

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Apr 17, 2025, 7:45 PM EDT - 1 year ago

XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

XORTX Announces Change of Auditor

Jan 17, 2025, 5:00 PM EST - 1 year ago

XORTX Announces Change of Auditor

XORTX Announces Presentation at the Rare and Genetic Disease Summit

Dec 12, 2024, 9:17 AM EST - 1 year ago

XORTX Announces Presentation at the Rare and Genetic Disease Summit

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

Oct 18, 2024, 4:00 PM EDT - 1 year ago

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement

XORTX Initiates Precision Medicine Program

Oct 9, 2024, 5:00 AM EDT - 1 year ago

XORTX Initiates Precision Medicine Program

XORTX Announces Results of Annual and Special Meeting of Shareholders

Sep 13, 2024, 7:00 AM EDT - 1 year ago

XORTX Announces Results of Annual and Special Meeting of Shareholders

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A

Sep 12, 2024, 5:30 PM EDT - 1 year ago

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

Sep 6, 2024, 5:30 PM EDT - 2 years ago

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders

Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders

Sep 3, 2024, 12:30 PM EDT - 2 years ago

Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

Aug 23, 2024, 7:00 AM EDT - 2 years ago

XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders

XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024

Aug 20, 2024, 7:00 AM EDT - 2 years ago

XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

May 17, 2024, 7:00 AM EDT - 2 years ago

XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

Apr 30, 2024, 1:54 PM EDT - 2 years ago

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

XORTX Announces Publication of Key Research in ADPKD

Apr 22, 2024, 7:00 AM EDT - 2 years ago

XORTX Announces Publication of Key Research in ADPKD

XORTX Welcomes New Member to the Board of Directors

Apr 8, 2024, 7:30 AM EDT - 2 years ago

XORTX Welcomes New Member to the Board of Directors

XORTX Announces New Clinical Advisory Board Member

Mar 27, 2024, 5:00 AM EDT - 2 years ago

XORTX Announces New Clinical Advisory Board Member

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial

Mar 19, 2024, 5:00 AM EDT - 2 years ago

XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial

XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units

Mar 4, 2024, 7:00 AM EST - 2 years ago

XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units

XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units

Feb 1, 2024, 8:46 PM EST - 2 years ago

XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units

XORTX Announces $2 Million Public Offering

Jan 15, 2024, 7:00 AM EST - 2 years ago

XORTX Announces $2 Million Public Offering

XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

Jan 3, 2024, 7:00 AM EST - 2 years ago

XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

XORTX Announces US ATM Offering

Nov 30, 2023, 7:30 AM EST - 2 years ago

XORTX Announces US ATM Offering

XORTX Meets Nasdaq Continued Listing Requirements

Nov 29, 2023, 7:00 AM EST - 2 years ago

XORTX Meets Nasdaq Continued Listing Requirements

XORTX Clarifies Timing for Share Consolidation

Nov 10, 2023, 7:00 AM EST - 2 years ago

XORTX Clarifies Timing for Share Consolidation

XORTX Announces Results of Special Meeting of Shareholders

Oct 27, 2023, 5:30 PM EDT - 2 years ago

XORTX Announces Results of Special Meeting of Shareholders

XORTX Announces Date for Rescheduled Special Meeting of Shareholders

Oct 25, 2023, 5:00 PM EDT - 2 years ago

XORTX Announces Date for Rescheduled Special Meeting of Shareholders

XORTX Announces Rescheduling of Special Meeting of Shareholders

Oct 25, 2023, 7:00 AM EDT - 2 years ago

XORTX Announces Rescheduling of Special Meeting of Shareholders

XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution

Oct 12, 2023, 7:00 AM EDT - 2 years ago

XORTX Reports that Independent Proxy Firm, ISS, Recommends Shareholders Vote for the Share Consolidation Resolution

taxidriver514
taxidriver514 Sep. 4 at 4:25 PM
$BIAF $CYCU $XRTX
0 · Reply
focafoca99
focafoca99 Sep. 4 at 1:09 PM
$XRTX terminated its prior IR agency agreement and re-engaged IR Agency after completing its TSX Venture delisting.
0 · Reply
LookaLike
LookaLike Sep. 2 at 8:46 PM
$XRTX going up
1 · Reply
focafoca99
focafoca99 Aug. 28 at 11:19 AM
$XRTX terminated its investor-relations agreement and postponed the program while it pursues a TSX-V delisting.
0 · Reply
LookaLike
LookaLike Aug. 28 at 6:59 AM
$XRTX this was a tenbagger in the past, I remember a few years ago it went to the moon. Problem was that it never held the gains and it always came back
0 · Reply
honestrick
honestrick Aug. 27 at 9:18 PM
$XRTX 2,198 watchers just a start ....GLTA....
0 · Reply
LookaLike
LookaLike Aug. 27 at 3:16 PM
$XRTX going Up again
0 · Reply
LookaLike
LookaLike Aug. 27 at 12:27 PM
$XRTX why the premarket Volume, I see no news
0 · Reply
honestrick
honestrick Aug. 27 at 11:55 AM
$XRTX Would be nice ...
0 · Reply
LookaLike
LookaLike Aug. 25 at 6:29 PM
$XRTX IT IS moving
0 · Reply
LookaLike
LookaLike Aug. 8 at 9:15 PM
$XRTX when will it move?
0 · Reply
Biotech80
Biotech80 Jul. 7 at 10:51 AM
$XRTX 💎💎💎💎
0 · Reply
Biotech80
Biotech80 Jun. 29 at 8:23 AM
$XRTX
0 · Reply
Biotech80
Biotech80 Jun. 26 at 12:31 PM
$XRTX let’s go going to be a great few days 🚀🚀🤑💎💎💎💎💎
0 · Reply
LookaLike
LookaLike Jun. 18 at 6:25 PM
$XRTX a turtle is moving faster than this
0 · Reply
honestrick
honestrick Jun. 16 at 1:14 AM
$XRTX Voluntarily delisting from the tsx venture .Good riddance . Shares will convert over to the Nasdaq .. Things will start to move now ...Up I hope .
0 · Reply
DARKP00L
DARKP00L Jun. 15 at 12:04 PM
$XRTX 07:49 on Jun. 15 2026 XORTX Therapeutics Appoints Mika Grasso Co-CEO #tradeideas
0 · Reply
focafoca99
focafoca99 Jun. 15 at 11:50 AM
$XRTX appointed Mika Grasso as co-CEO to drive its gout and kidney program strategy.
0 · Reply
LookaLike
LookaLike Jun. 4 at 7:32 AM
$XRTX new presentation out, IND and NDA filing postponed again. NDA postponed into H2 2027. It shouldve been a short timeline to NDA review but now it turns out to be a long one.
0 · Reply
LookaLike
LookaLike May. 19 at 5:52 PM
$XRTX offering closed, cash position is higher than marketcap now
0 · Reply